INSIGHTS ON DRUG DEVELOPMENT
-
Peptones And Vaccines: A Synergistic Approach To Enhanced Production And Efficiency
Enhance your vaccine manufacturing with peptones. Explore their benefits, analyze data-driven productivity gains, and learn integration strategies in this informative, on-demand session.
-
Developing High Concentration Biopharmaceuticals: Formulation Considerations
This session addresses key obstacles—such as opalescence, viscosity, and aggregation—and presents case studies on how composition changes during the concentration process can be effectively characterized.
-
Your Guide To Precise And Robust Separation Methods
Discover a detailed guide to characterizing GLP-1 receptor agonists that covers advanced LC-MS and SEC-MALS workflows for impurity profiling, stability testing, and aggregate analysis.
-
Label-Free Analysis Of Multiple Spheroids In A Matrix
Gain insight into how automated z-stack imaging and AI-based analysis enable accurate, label-free monitoring of spheroid development in 3D matrices for drug screening and cell culture workflows.
-
Advancements In GLP-1 Analog Formulation: Overcoming Challenges2/3/2025
Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.
-
The Key To HPAPI Manufacturing Success3/1/2024
Watch to explore a training center dedicated to the development and manufacturing of HPAPIs that is setting a new industry standard for safety and expertise.
-
UPLC-MS/MS Determination Of GLP-1 Analogue7/17/2025
Discover a robust, evaporation-free method for analyzing liraglutide in human plasma using LC-MS/MS to ensure high sensitivity, reproducibility, and improved analyte recovery.
-
Evaluating CAR T-Cell Therapy Recruitment And Efficacy4/17/2024
Learn about Organ-on-a-Chip technology and how it can be employed to assess the efficacy of CAR T-cell therapies against solid tumors.
-
Characterization Of The Colon Intestine-Chip3/14/2024
Learn about the development and characterization of Organ-Chips and what makes them the most comprehensive model of the colonic epithelial-endothelial interface that is commercially available.
DRUG DEVELOPMENT SOLUTIONS
-
Sterility is key for high-risk applications such as injectables, parenteral formulations, ophthalmic and peritoneal dialysis solutions, and many more.
-
Explore how key biomarkers like Amyloid-beta, TAU, and α-Synuclein are transforming neurodegeneration research, with enhanced detection strategies that improve diagnostic accuracy.
-
Learn about a manufacturing site with over 35 years of expertise in bioconjugation, APIs, excipients, and adjuvants manufacturing that helps clients accelerate drug development programs worldwide.
-
Improve precision in ADME and Toxicology applications with a low-drug-absorption profile.
-
Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to inadequate insulin production or impaired insulin utilization, commonly known as insulin resistance.